Liang J, Zhao Z, Xie Y, Lai D, Okereke I, Velotta J
Transl Cancer Res. 2025; 14(1):613-625.
PMID: 39974376
PMC: 11833366.
DOI: 10.21037/tcr-2024-2402.
Naemi A, Tashk A, Sorayaie Azar A, Samimi T, Tavassoli G, Bagherzadeh Mohasefi A
Cancers (Basel). 2025; 17(3).
PMID: 39941923
PMC: 11817159.
DOI: 10.3390/cancers17030558.
Wu Y, Wu L, Ou J, Tang S, Cao J, Fu M
Abdom Radiol (NY). 2024; 50(3):1123-1132.
PMID: 39305294
DOI: 10.1007/s00261-024-04585-1.
Shah S, Khan A, Seder C
Ann Surg Oncol. 2024; 31(12):7659-7660.
PMID: 39068311
DOI: 10.1245/s10434-024-15908-3.
Sundbom M, Linder G
J Thorac Dis. 2024; 16(6):3535-3539.
PMID: 38983140
PMC: 11228716.
DOI: 10.21037/jtd-23-1898.
Hypoxia‑regulated exosomal miR‑185 inhibits esophageal squamous cell carcinoma progression and predicts prognosis.
Maiyulan A, Matsumoto Y, Wang H, Murakami K, Toyozumi T, Otsuka R
Oncol Lett. 2024; 28(1):334.
PMID: 38827568
PMC: 11140231.
DOI: 10.3892/ol.2024.14467.
Nomogram based on multimodal magnetic resonance combined with B7-H3mRNA for preoperative lymph node prediction in esophagus cancer.
Xu Y, Lu P, Gao M, Wang R, Li Y, Guo R
World J Clin Oncol. 2024; 15(3):419-433.
PMID: 38576593
PMC: 10989267.
DOI: 10.5306/wjco.v15.i3.419.
Long-term clinical outcomes and prognosis after definitive radiotherapy for patients with cervical esophageal squamous cell carcinoma: a single-institution retrospective study.
Zhang S, Sun J, Pan X, Kim J, Zhu W, Zhou Y
J Thorac Dis. 2024; 15(12):6976-6987.
PMID: 38249918
PMC: 10797353.
DOI: 10.21037/jtd-23-1789.
Tumor differentiation impacts response to neoadjuvant therapy and survival in patients with esophageal adenocarcinoma.
McKay S, Louie B, Molena D, Andrews W, Boerner T, Hofstetter W
J Thorac Cardiovasc Surg. 2023; 167(6):1943-1950.
PMID: 37788788
PMC: 11791758.
DOI: 10.1016/j.jtcvs.2023.09.055.
Lymphatic flow mapping using near-infrared fluorescence imaging with indocyanine green helps to predict lymph node metastasis intraoperatively in patients with esophageal or esophagogastric junction cancer not treated with neoadjuvant chemotherapy.
Shiomi S, Yagi K, Iwata R, Yajima S, Okumura Y, Aikou S
Surg Endosc. 2023; 37(11):8214-8226.
PMID: 37653159
PMC: 10615981.
DOI: 10.1007/s00464-023-10368-4.
Prognostic implications of the extent of downstaging after neoadjuvant therapy for oesophageal adenocarcinoma and oesophageal squamous cell carcinoma.
Kamarajah S, Markar S, Low D, Phillips A
BJS Open. 2023; 7(3).
PMID: 37341158
PMC: 10282921.
DOI: 10.1093/bjsopen/zrad042.
Development and validation of the novel subclassification of pN3 for patients with esophageal cancer.
Ma K, Wang H, Fang C, Jiang X, Ma J
Front Oncol. 2023; 13:1113711.
PMID: 37205185
PMC: 10187992.
DOI: 10.3389/fonc.2023.1113711.
Risk factors of lymph node metastasis or lymphovascular invasion for superficial esophageal squamous cell carcinoma: A practical and effective predictive nomogram based on a cancer hospital data.
Tao Y, Chen S, Yu J, Shen Q, Ruan R, Wang S
Front Med (Lausanne). 2022; 9:1038097.
PMID: 36465939
PMC: 9713002.
DOI: 10.3389/fmed.2022.1038097.
Comparison of clinicopathological features and prognostic significance between synchronous multiple primary and solitary esophageal squamous cell carcinomas.
Yang Y, Tang P, Ma M, Zhang H, Wang H, Zhu K
BMC Cancer. 2022; 22(1):1191.
PMID: 36401209
PMC: 9675276.
DOI: 10.1186/s12885-022-10283-2.
Radiomics models based on CT at different phases predicting lymph node metastasis of esophageal squamous cell carcinoma (GASTO-1089).
Peng G, Zhan Y, Wu Y, Zeng C, Wang S, Guo L
Front Oncol. 2022; 12:988859.
PMID: 36387160
PMC: 9643555.
DOI: 10.3389/fonc.2022.988859.
Development and validation of a nomogram model for the prediction of 4L lymph node metastasis in thoracic esophageal squamous cell carcinoma.
Xu L, Guo J, Qi S, Xie H, Wei X, Yu Y
Front Oncol. 2022; 12:887047.
PMID: 36263210
PMC: 9573997.
DOI: 10.3389/fonc.2022.887047.
Development and validation of nodal staging score in pN0 patients with esophageal squamous cell carcinoma: A population study from the SEER database and a single-institution cohort.
Wang H, Yang Y, Zhu K, Zhu N, Gong L, Zhang H
Thorac Cancer. 2022; 13(23):3257-3267.
PMID: 36221304
PMC: 9715890.
DOI: 10.1111/1759-7714.14670.
Prediction of Individual Lymph Node Metastatic Status in Esophageal Squamous Cell Carcinoma Using Routine Computed Tomography Imaging: Comparison of Size-Based Measurements and Radiomics-Based Models.
Xie C, Hu Y, Han L, Fu J, Vardhanabhuti V, Yang H
Ann Surg Oncol. 2022; 29(13):8117-8126.
PMID: 36018524
DOI: 10.1245/s10434-022-12207-7.
Residual lymph node disease and mortality following neoadjuvant chemoradiation and curative esophagectomy for distal esophageal adenocarcinoma.
Kandilis A, Iniguez C, Khalil H, Mazzola E, Jaklitsch M, Swanson S
JTCVS Open. 2022; 5:135-147.
PMID: 36003158
PMC: 9390677.
DOI: 10.1016/j.xjon.2020.12.001.
Machine learning applications in upper gastrointestinal cancer surgery: a systematic review.
Bektas M, Burchell G, Bonjer H, van der Peet D
Surg Endosc. 2022; 37(1):75-89.
PMID: 35953684
PMC: 9839827.
DOI: 10.1007/s00464-022-09516-z.